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Embryo development and implantation are dynamic processes, responsive to external signals, and can 
potentially be influenced by many environmental factors. The aims of this study were to evaluate the 
effects of a culture medium supplemented with amniotic-derived microvesicles (MVs) on in vitro embryo 
hatching after cryopreservation, and pregnancy rate following embryo transfer. In addition, miRNA 
profiling of blastocysts produced in vitro, with or without (control; CTR) amniotic MV supplementation, 
was also evaluated using blastocysts produced in vivo. In vitro embryos were cultured with and without 
amniotic MV supplementation. In vivo blastocysts were obtained from superovulated cows. Samples 
for RNA isolation were obtained from three pools of 10 embryos each (in vivo, in vitro-ctR and in 
vitro + MVs). Our results show that the hatching percentage of cryopreserved in vitro + MVs embryos 
is higher (P < 0.05) than in vitro-CTR embryos and the pregnancy rate with fresh and cryopreserved 
in vitro + MVs embryos is higher than in vitro-CTR embryos. In addition, the analysis of differently 
expressed (DE) microRNAs showed that embryos produced in vivo are clearly different from those 
produced in vitro. Moreover, in vitro-ctR and in vitro + MVs embryos differ significantly for expression 
of two miRNAs that were found in higher concentrations in in vitro-CTR embryos. Interestingly, these 
two miRNAs were also reported in degenerated bovine embryos compared to good quality blastocysts. 
In conclusion, MV addition during in vitro production of embryos seems to counteract the adverse 
effect of in vitro culture and partially modulate the expression of specific miRNAs involved in successful 
embryo implantation.
In the mammalian reproductive tract, the oviduct secretes a variety of growth factors and cytokines, which may 
play an essential role in the development of initial stages of pre-implantation embryos1. The absence of these 
maternal-embryo signals could be an important cause of the poor quality of in vitro produced embryos (IVP), 
compared to those collected in vivo2,3. To mimic the in vivo crosstalk between oviduct and embryo and to improve 
the quality of in vitro produced embryos, co-culture systems with somatic cells have been widely used to increase 
blastocyst percentage and quality of the resulting embryos, and the induction of specific transcriptomic changes4.
Unfortunately, concern regarding viral transmission has resulted in the elimination of co-culture and the 
development of improved culture methods characterized by definite medium as synthetic oviductal fluid with 
amino acids (SOFaa5). However, the maternal-embryo communication in vivo and the communication between 
monolayer (‘helper’) cells and embryos in vitro, take place not only through soluble factors (growth factors, recep-
tors and binding proteins) secreted by cells and embryos in the medium6,7 but also from insoluble factors. Recent 
studies have demonstrated that some molecules, including mRNA fragments and microRNAs (miRNAs), cannot 
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freely cross the membrane and are thus released into the extracellular vesicle (EV) before its release from the 
cells8. In addition to genetic material, EVs contain molecules such as cytoskeletal proteins, immunoregulator 
molecules, signal transduction molecules, tetraspanins, heat shock protein, lipid rafts, etc9. The EVs can be cat-
egorized as exosomes or microvesicles (MVs), depending on the mechanisms responsible for their biogenesis. 
Exosomes, derived from multivesicular bodies, are released after fusion with the plasma membrane and vary 
in size from 30 to 100 nm, while MVs are formed and shed directly from the plasma membrane and have a size 
between 100–1000 nm10. Extracellular vesicles can be detected in all body fluids as well as in culture medium 
collected from different cell lines8 and appear to be the major mechanism by which cells communicate with their 
environment.
Until now no one has studied the role of EVs in paracrine mechanisms in vitro however, it is important to 
develop an effective embryo culture medium that might eventually also improve the efficacy of human embryo 
culture programs.
To improve the quality of in vitro produced bovine embryos, in our previous study11 bovine embryos were 
co-cultured with endometrial or amniotic-derived EVs. Using Nanosight and transmission electron microscope 
evaluation, these EVs were identified as MVs, based on their size and biogenesis. During the co-culture, amniotic 
or endometrial derived-MVs labelled with PKH26 were internalized into bovine blastomeres but the amniotic 
derived MVs have a number of effects on the embryo: increase the number of cells constituting the inner cell 
mass, improving quality, increasing viability, increasing expression of GPX1 gene (protective against lipid per-
oxidation) and reducing expression of BAX gene (involved in apoptosis) compared to endometrial MVs and 
control (CTR). The amniotic secretome appears to better support in vitro embryo growth than the endometrial 
secretome. This result was surprising but it is likely that endometrial cells de-differentiate during culture in mon-
olayers by losing cell polarity, cell height, ciliation, secretory activity, and responsiveness to hormones12–15. In this 
way, the secretions produced by endometrial cells in vitro are different from the in vivo secretions. Moreover, it is 
probable that amniotic and endometrial secretomes contain different components attributable to the different age 
of this tissue (adult for endometrium and fetal for amnion) however, there is no data in the literature to support 
this hypothesis.
To further study the effects of amniotic-derived MVs on bovine embryos and to evaluate whether MVs may 
potentially influence embryo implantation, we analysed in vitro embryo hatching after cryopreservation and 
pregnancy rate following embryo transfer.
In addition, the profiles of microRNAs (miRNAs) were characterized in in vitro produced embryos with and 
without MV supplementation as well as in in vivo produced embryos. The miRNAs are non-coding RNA mole-
cules of about 22 nucleotides in length that can modulate transcription/expression levels of many target genes16,17.
The regulatory properties of miRNAs and their roles in mammalian gametogenesis and signaling in the 
context of embryonic development and implantation is well documented18,19. In addition, miRNAs have been 
reported to serve as non-invasive biomarkers to assess preimplantation developmental competence and embryo 
selection20.
Results
Amniotic cell isolation and characterization by reverse transcription-PCR analysis. Amniotic 
derived cells (AMCs) showed a typical stem cell phenotype (Fig. 1A) and expressed MSC (CD29, CD44, CD105, 
CD166) but not hematopoietic (CD34 and CD14) markers. No expression of the Major Histocompatibility 
Complex, class II (MHC-II) was detected although MHC-I was found. Moreover, MSCs were found to express 
Oct-4 and c-Myc (Fig. 1B). These data are in concordance with those reported by Lange-Consiglio et al.21.
EV identification. NanoSight analysis determined that amniotic EVs had a dimension between 75 nm and 
700 nm, with a mean of 275 ± 8.4 nm (Fig. 2). These characteristics, classify these EVs as microvesicles (MVs).
percentage of in vitro produced embryos. A total of 3782 oocytes were fertilized over the course of 
18 replicates. Embryo morphology was evaluated on day 7 after fertilization under a stereomicroscope (Leica 
microsystems, Milan, Italy) and the embryos were grouped according to their development stage (morula, com-
pact morula, and blastocyst). Poor quality morulas/compact morulas were classified as degenerate if there was a 
loss of plasma membrane integrity (lysis) and/or generalized loss of cell forms.
The percentage of B7 was 34.59 ± 1.32% (709/2050) in in vitro-CTR and 34.24 ± 1.71% (593/1732) in in 
vitro + MVs (P > 0.05) (Table 1).
Survival percentage after cryopreservation. After cryopreservation, embryo survival, in terms of 
hatching blastocysts, was statistically different (P < 0.05) between in vitro-CTR (32.71 ± 6.26%; 87/266) and in 
vitro + MVs (43.09 ± 5.73%; 78/181), respectively (Table 1).
Percentage of pregnancy after embryo transfer. On day 28 (D28), the pregnancy rate was statistically 
different (P < 0.05) after embryo transfer of fresh embryos, 36.67% (11/30 cows) for in vitro-CTR and 66.67% 
(20/30 cows) for in vitro + MVs. There was also a statistically significant difference (P < 0.05) in pregnancy 
rate for transfer of cryopreserved embryos: 10% (3/30) for in vitro-CTR embryos versus 36.67% (11/30) for in 
vitro + MV (Table 1). On day 70 (D70), the pregnancy rate decreased to 3.34% for both fresh and cryopreserved 
in vitro-CTR embryos, while for in vitro + MVs embryos no late embryo mortality was recorded for either fresh 
or cryopreserved embryos (Table 1).
In vivo embryo production. After superovulation in three cows, 34 embryos were collected, with an aver-
age of 11.36 ± 1.42 embryos.
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miRNA data analysis. Nine samples were sequenced, each from a pool of 10 embryos, belonging to three 
groups (in vivo, in vitro-CTR and in vitro + MVs) (see Supplementary File S1 for statistics).
About 35 million reads were sequenced for each condition and replicate, 1% of which were assigned to miR-
NAs. In total, 294 miRNAs were identified at least in triplicate in one group (197 Bos taurus bta-miRNAs, 52 
novel and 45 novel homologous to related species).
Principal Component Analysis (PCA) on these miRNAs showed that in vivo produced embryos were clearly 
different from in vitro produced embryos (PC1). The two groups of embryos obtained following in vitro culture 
clustered close to one another, but the in vitro + MVs group was closer to in vivo samples (Fig. 3A).
The number of miRNAs found to be differentially expressed ((DE)-miRNAs) in three comparisons (in vivo 
vs in vitro + MVs, in vivo vs in vitro-CTR, in vitro-CTR vs in vitro + MVs) were 15, 20 and 2, respectively (False 
Discovery Rate (FDR) < 0.05) (Supplementary File S2). PCA calculated on DE-miRNAs showed a separation 
of the three groups with a distinctive miRNA trait (Fig. 3B). PC1, which explains 62.4% of the variance, clearly 
separates in vivo and in vitro produced embryos even if MV addition seems to ameliorate the effect of in vitro 
Figure 1. (A) Amniotic cell morphology. Magnification 20X, scale bar 20 µm. (B) RT-PCR analysis of 
mesenchymal (CD29, CD44, CD105, CD166), pluripotent (Oct-4 and c-Myc) and haematopoietic (CD34, CD14) 
markers on AMCs at P3. Major Histocompatibility Complex (MHC) I and II gene expression is also reported.
Figure 2. NanoSight analysis. Results from analysis of MVs purified from amniotic cells. Nanoparticle Tracking 
Analysis software allows the analysis of video images of the particle movement calculating the mean size and 
particle concentration values. The curve describes the relationship between particle number distribution (left 
Y-axis) and particle size (X-axis).
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production. Three DE-miRNAs (bta-miR-10a, bta-miR-486 and bta-let7-e) are shared among the in vivo and the 
two in vitro groups (Fig. 3). Finally, the expression of two miRNAs (miR 130a, miR-181b) differed significantly 
between in vitro embryos obtained with or without MVs (Fig. 4).
miRNA validation by quantitative polymerase chain reaction (q-PCR). Five miRNAs (bta-let-
7a-5p, bta-miR-130a, bta-miR-34a, bta-miR-423-5p, bta-miR-486) were validated by q-PCR using two refer-
ence smallRNAs (SNORD95 and RNU6). The fold change among three groups (in vivo, in vitro-CTR and in 
vitro + MVs) were compared with those of miRNA sequencing (Supplementary File S3). qPCR confirmed 
smallRNA-seq pattern: bta-let-7a-5p was validated with both smallRNA references, whereas bta-miR-130a and 
bta-miR-34a were validated with RNU6 and bta-miR-423-5p, bta-miR-486 with SNORD95.
Experimental conditions In vitro-CTR In vitro + MVs
Rate of embryo production (709/2050)34.59 ± 1.32%a
(593/1732)
34.24 ± 1.71%a
Survival percentage after cryopreservation (87/266)32.71 ± 6.26%a
(78/181)
43.09 ± 5.73%b
Pregnancy rate after fresh embryo transfer (D28) (11/30)36.67%a
(20/30)
66.67%b
Pregnancy rate after cryopreserved embryo transfer (D28) (3/30)10%a
(11/30)
36.67%b
Pregnancy rate after fresh embryo transfer (D70) (10/30)33.33%a
(20/30)
66.67%b
Pregnancy rate after cryopreserved embryo transfer (D70) (2/30)6.67%a
(11/30)
36.67%b
Table 1. Data obtained under different experimental conditions in vitro and in vivo. Different small letters 
superscript (a,b) in the same line indicate statistically different comparisons (p < 0.05) between In vitro-CTR 
and In vitro + MVs.
Figure 3. Principal component analysis showing: (A) the 294 miRNAs present at least in triplicate in one 
condition, (B) the 34 DE-miRNAs.
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Discussion
In recent years, the roles of EVs in biological processes such as implantation and embryo development8 have been 
widely investigated. The supplementation of in vitro embryo culture medium with bovine amniotic derived MVs 
has been shown to improve the quality of bovine embryos11. To understand the effects of amniotic-derived MVs on 
bovine embryos and their potential influence on embryo implantation, we performed a further in vitro and in vivo 
study. The results show that the hatching percentage of cryopreserved in vitro + MVs embryos is higher compared 
to the in vitro-CTR embryos. In addition, in vivo, the D28 recipient pregnancy rates are higher with both fresh and 
cryopreserved in vitro + MVs embryos compared in vitro-CTR embryos. At D70, late embryonic loss was found 
only in both fresh and cryopreserved in vitro-CTR embryos, while no late embryo mortality was recorded in in 
vitro − MV embryos. From these results, it can be concluded that the MVs had a positive effect on both the sur-
vival of frozen/thawed embryos and their implantation rates. We do not know how the MVs improve the implan-
tation efficiency. It is likely that MV supplementation reduces apoptosis11 and degeneration and this assumption 
could explain the higher hatching rate in cryopreserved in vitro + MVs embryos and the higher recipient preg-
nancy rate in vivo with both fresh and cryopreserved in vitro + MVs embryos compared to in vitro-CTR embryos. 
Since it has recently been proposed that miRNAs could serve as molecular markers of blastocyst quality20,22,23, 
we wanted to investigate whether miRNAs could be related to the success of hatching and implantation. To this 
end, embryo miRNA profiling in the different embryo culture conditions (in vitro, with or without MVs, and in 
vivo) was performed.
It is known that messenger RNA and miRNA can be transferred from spermatozoa to the oocyte at fertiliza-
tion24 and that altered spermatozoan mRNA profiles could influence in vitro fertilization25. In order to minimize 
the bull effect, ejaculate from a single bull of proven fertility was used.
To our knowledge, this is the first study reporting the complete miRNA profiling of blastocysts fertilized in 
vitro compared with those collected in vivo. Few studies have investigated the importance of specific miRNAs in 
successful embryonic development. For example, a consistent downregulation of miR-199-5p was seen in murine 
embryos fertilized in vitro compared with those fertilized in vivo26.
Our results show that miRNAs represent only a small proportion of the total small non-coding RNA (ncRNA) 
content in blastocysts. SmallRNA profiling of pools of 30 bovine blastocysts using deep sequencing showed that 
the vast majority of reads mapped to ncRNAs other than miRNAs, as previously demonstrated by Pasquariello 
et al.27. Similarly, only about 1% of the total reads sequenced in our experimental conditions was assigned to 
miRNAs.
In our work, the miRNA profiles of the three groups under study (in vivo, in vitro-CTR and in vitro + MVs) are 
different, and each group shows a distinctive miRNA trait. In the DE-miRNAs PCA, it is interesting to note that 
PC1, accounting for 62.4% of the variance, clearly separates in vivo and in vitro groups, and that three miRNAs 
were commonly up-regulated in in vivo vs in vitro produced embryos: let-7e, miR-10a and miR-486. miRNAs 
were also validated by qPCR.
It is reported that the let-7 family members are essential for correct blastocyst maturation28 and these are 
differently expressed in mouse uterus during the peri-implantation period29. Specifically, in rats, let-7a expres-
sion was observed to change temporally and spatially in the uterus, playing an important role in blastocyst 
implantation and decidualization and in the mutual relationship between the receptive uterus and competent 
Figure 4. Venn Diagram of the differentially expressed (DE)-miRNAs for the three comparisons (in vivo vs in 
vitro + MVs, in vivo vs in vitro-CTR, in vitro + MVs vs in vitro-CTR).
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blastocyst29. In addition, the miRNA let-7e is also involved in embryo implantation. However, there are conflict-
ing data on the extent of expression of the let-7 family members, as downregulation in 5-aza-dC treated mouse 
pronuclear embryos (with inhibition of DNA methylation) alters embryo development30. On the other hand, the 
forced-expression of let-7a in dormant mouse blastocysts, activated by estradiol, reduces blastocyst attachment 
and outgrowth in vivo and in vitro, providing the first evidence that the let-7 family is involved in regulating the 
implantation process31. Our results show that let-7 family members are more strongly expressed in in vivo- than 
in in vitro produced blastocysts which contradicts the results of Liu et al.31 but it is likely that the expression of 
let-7a in murine blastocysts was excessively forced (about 100 times above physiological conditions), negatively 
affecting the implantation competency of the activated blastocysts.
MiR-10a is encoded in the Hox clusters upstream of HoxB4 gene and has been shown to target several HOX 
transcripts, suggesting a co-regulation with the neighbouring Hox genes and a role as a developmental regu-
lator32. In cultured embryos, ethanol treatment up-regulates miR-10a in mice and induces major fetal terato-
genesis33. Mis-regulation of miR-10a caused by ethanol exposure is, therefore, lethal for the embryo and fetus. 
Interestingly, co-incubation with folic acid blocks ethanol-induced teratogenesis, down-regulates miR-10a and 
improves the blastocyst development33. Conversely, we found a higher level of miR-10a in in vivo vs in vitro blas-
tocysts, suggesting that a minimum level of miR-10a is necessary for correct blastocyst maturation.
To date, there is no information in the literature regarding miR-486 apart from data concerning the signifi-
cantly increased expression of miR-486-3p in the mouse placental villus during the peri-implantation period34. 
The higher expression of this miRNA in in vivo blastocysts compared to those produced in vitro, shown for the 
first time in our study, highlights the importance of this miRNA for correct blastocyst growth. These findings, 
however, need further investigation.
Our data show that in vitro embryo production modifies miRNA content in the blastocyst. The supplementa-
tion of culture medium with MVs seems to partially change the miRNA profile of in vitro + MVs embryos com-
pared to in vitro-CTR embryos. Two miRNAs were significantly different between in vitro embryos obtained in 
the two conditions: miR-130a and miR-181b, which undergo up-regulation in in vitro-CTR embryos. These miR-
NAs were previously reported to regulate blastocyst development and embryo implantation. Mir-130a expression 
was observed to increase linearly during the 1–8 cell stage, but drastically decrease in the blastocyst, suggesting 
that miR-130a has a critical role in gene regulation in early bovine embryo development18,35.
MicroRNAs are also involved in fetal-maternal crosstalk. A uterine down-regulation of expression of miRNA-
181 family members is associated with the onset of embryo implantation that occurs in mice on the evening 
of day 4-post coitus36. Our results suggest that these two miRNAs have to be down-regulated during embryo 
development. However, in vitro culture without MVs induces up-regulation of these two miRNAs. There was over 
expression of miR-181a in degenerate bovine embryos compared to healthy bovine embryos37 and mir-181b, and 
with miR-191-5p, were the miRNA most released into the conditioned medium by human embryos38. Our data on 
in vitro-CTR embryos confirm this up-regulation and demonstrate that MV supplementation modifies miRNA 
expression ameliorating the quality of in vitro produced embryos.
conclusion
In conclusion, small RNA profiling showed a different miRNA expression between in vivo and in vitro produced 
blastocysts. This is likely to be due to epigenetic effects related to the different environmental culture conditions. 
Addition of amniotic MVs during in vitro embryo production seems to influence the developmental capacity and 
implantation potential of the embryos and regulate the expression of specific miRNAs (miR-130a and miR-181b) 
that regulate blastocyst development; these effects are involved in the success of embryo implantation, probably 
improving cross-talking between embryo and endometrium.
Further studies relating to other cargo components of the MVs are required, but in the meantime, these results 
could contribute to optimization of bovine embryo culture methods, and suggest new ways to improve human 
embryo culture technique.
Materials and Methods
Chemicals were obtained from Sigma-Aldrich Chemical (Milan, Italy) unless stated otherwise, and tissue culture 
plastic dishes were purchased from Euroclone (Milan, Italy).
Ovaries were collected from Holstein Friesian cows slaughtered in a slaughterhouse (INALCA, Ospedaletto 
Lodigiano, Lodi, Italy) under national food hygiene regulations.
Allanto-amniotic membranes were obtained at term from normal pregnancies and parturitions from three 
Holstein Friesian cows (Bos taurus). All procedures were performed according to approved animal care and 
use protocols of the Università degli Studi di Milano ethics committee (OPBA 118_2017) and to good veteri-
nary practice for animal welfare as to European directive 2010/63/UE. Moreover, written informed consent was 
obtained from farmers at the beginning of the study.
Amniotic cell isolation and culture. Allanto-amniotic membranes were collected and processed follow-
ing a standard protocol as previously reported21. Briefly, the allanto-amnion were kept at 4 °C and processed 
within 12 h. The amniotic membrane was separated from its juxtaposed allantois and cut into small pieces (about 
9 cm2 each) that were digested with 0.93 mg/ml collagenase type I and 20 mg/ml DNAse (Roche, Mannheim, 
Germany) for approximately 3 h at 38.5 °C. Debris were removed using a 100 mm cell strainer and mobilized cells 
were collected by centrifugation at 200 × g for 10 min. Amniotic cells were cultured in a medium composed of 
HG-DMEM supplemented with 10% fetal calf serum (FCS), 1% penicillin (100 UI/mL)–streptomycin (100 mg/
mL), 0.25 mg/mL amphotericin B and 2 mM L-glutamine at 38.5 °C in a humidified atmosphere of 5% CO2 until 
passage (P) 3.
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Amniotic cell characterization by reverse transcription-PCR analysis. Some mesenchymal (CD29, 
CD44, CD105, CD166), pluripotent (Oct-4 and c-Myc) and haematopoietic (CD34, CD14) markers were evalu-
ated by RT-PCR analysis at P3. Expression of MHC-I and MHC-II was also evaluated. GAPDH was employed as 
a reference gene. Equine-specific oligonucleotide primers and conventional PCR were the same ones used for the 
standard characterization of these cells as reported by Corradetti et al.21.
Microvesicle isolation. Amniotic cells at P3 at confluence were cultured for one night in a serum-free 
medium (Ultraculture, Lonza, Milan, Italy). The microvesicle isolation was performed according to the protocol 
of Perrini et al.11. Briefly, the culture media from three amniotic membranes was collected, pooled, and cen-
trifuged at 3500 × g for 20 min to remove cellular debris. Then, MVs were obtained by ultra-centrifuging the 
pooled medium at 100,000 × g for 1 h at 4 °C (Beckman Coulter Optima L - 100 K). The pellet was washed in 
serum-free medium 199 containing N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) 25 mM and 
ultra-centrifuged again under the same conditions. The pellet of MVs was split for MV analysis or use in the in 
vitro study.
Measurements of MVs. As described by Bruno et al.39, size and concentration of MVs were evaluated by 
the NanoSight LM10 instrument (Nanoparticle tracking analysis, NTA, Nano-Sight Ltd., Amesbury, U.K.), which 
permits discrimination of microparticles less than 1 µm in diameter.
In vitro embryo production. The in vitro embryo production is a standard protocol composed of three 
steps: collection of oocytes and their in vitro maturation, in vitro fertilization, and in vitro culture of embryos. 
In our laboratory, these steps are standardized and performed according to the protocol of Perrini et al.11 and 
Lange-Consiglio et al.40.
Collection of oocytes and in vitro maturation (IVM). Ovaries were collected from slaughtered Holstein-Friesian 
cows (Bos Taurus) with unknown history (age, genealogy, and physiological status). Ovaries were transported 
to the laboratory in sterile saline solution (0.9% NaCl) supplemented with 150 mg/L kanamycin and maintained 
at 30 °C. Oocytes were retrieved by aspiration of 3–5 mm diameter follicles with 18 G needles. Cumulus–oocyte 
complexes (COCs) were selected and washed three times in pre-incubated TCM 199-Hepes buffered supple-
mented with 10% FCS.
In vitro maturation was performed under standard condition for 24 h in TCM 199 Earl’s Salt medium sup-
plemented with 10% FCS, 5 μg/mL LH (Lutropin, Vetoquinol, France), 0.5 μg/mL FSH (Folltropin, Vetoquinol), 
0.2 mM sodium pyruvate, 5 μg/mL gentamycin and 1 mg/mL estradiol 17β. Cultures were performed in 70 μL 
droplets (up to 20 oocytes/droplet) of the medium under mineral oil, at 38.5 °C in 5% CO2.
In vitro fertilization (IVF). In vitro fertilization was performed in Tyrode’s-albumin-lactate-pyruvate (TALP) 
medium containing 2 mM penicillamine, 1 mM hypotaurine, 250 mM epinephrine, 20 μg/mL heparin, 114 mM 
NaCl, 3.2 mM KCl, 0.4 mM NaH2PO4, 10 mM sodium lactate, 25 mM NaHCO3, 0.5 mM MgCl2-6H20, 
2.0 mM CaCl2-2H2O, 6 mg/mL bovine serum albumin (BSA,), 5 μl/mL gentamicin, 0.2 mM sodium pyruvate. 
Frozen-thawed semen from a single bull of proven fertility was prepared by Percoll density gradient (Amersham 
Pharmacia Biotec) (45/90%). Semen was thawed at 37 °C for 30 s, placed on the top of the Percoll gradient 
and centrifuged for 30 min at 300 × g. The semen suspension was diluted in the appropriate volume of fertili-
zation medium to obtain a final concentration of 107 spermatozoa per mL. An aliquot of 10 µL of semen was 
co-incubated with matured oocytes for 18 h at 38.5 °C in 5% CO2. Cultures were performed in 70 μl droplets (up 
to 20 oocytes/droplet) of the medium under mineral oil. At the end of gamete co-culture, cumulus cells were com-
pletely removed and cumulus-free presumptive zygotes were randomly transferred into different culture systems 
and cultured up to day 7.
In vitro culture (IVC). The standard medium for IVC was synthetic oviductal fluid with amino acids (SOFaa; 
Holm et al. 1999) composed of 1.1 M NaCl, 72 mM KCl, 12 mM KH2PO4, 7.4 mM MgSO4, 50 mM DL-lactate, 
250 mM NaHCO3, 260 mM phenol red, 100 mM sodium pyruvate, 178 mM CaCl2-2H2O, 125 mM Hepes 
sodium salt, 30.8 mM glutamine, 500 mM glycine, 84.2 mM alanine, 100X MEM non-essential, 100X BME, 
2.8 mM Myo-Inositol, 340 mM trisodium citrate, 2% FCS, 0.005 gr/mL BSA, 0.2 mM sodium pyruvate, 5 µL/mL 
gentamicin.
At the beginning of the culture in SOFaa, presumptive zygotes were randomly assigned to a control group 
(CTR, no supplementation), or to group in which SOFaa was supplemented with 100 × 106 EVs/ml as previously 
studied by Perrini et al.11 after dose-response curve.
In vitro culture was performed for 7 days in 5% O2, 5% CO2 and 90% N2 in a humidified atmosphere at 38.5 °C. 
Cultures were performed in 70 μl droplets (up to 20 oocytes/droplet) of the medium. In the standard protocol, the 
medium is renewed on days 3 and 6 during the culture period. In this study, to avoid stress to the embryos and to 
allow the action of MVs, the medium was renewed on days 3 and 5, and the day fifth was chosen to add MVs to 
SOF11. SOF only was also added to the control group on the same days.
On day 7, blastocysts from the control and MV groups were retrieved from the IVC drops. One set of grade 
1 blastocysts, according to International Embryo Technology Society41 classification system, either fresh or cry-
opreserved was used for embryo transfer. Another set (ten blastocysts for each group) was washed in sterile PBS 
and immediately cryopreserved in liquid nitrogen for genomic study.
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Cryopreservation of blastocysts and warming. Excellent quality blastocysts collected on day 7 (B7) 
were cryopreserved with ethylene glycol 1.5 M using a standard slow freezing curve. Thawing was accomplished 
by removing the cryoprotectant by washing in PBS supplemented with 0.2% BSA. Embryos were cultured in 
SOFaa and their in vitro survival and growth were evaluated for the 3 days before hatching.
Recipient animals. One hundred and twenty Holstein-Friesian cows were enrolled in this study as recipients 
of an in vitro produced embryo. Written informed consent was obtained from the owners and the cows were used 
in accordance to the approved ethics application. No adverse outcomes were observed during synchronization, 
embryo transfer or pregnancy.
Synchronization of oestrus, embryo transfer and pregnancy diagnosis. Recipient heifers were 
synchronized by a luteolytic dose of Prostaglandin PGF2-α (Estrumate, Schering Plough Animal Health, Segrate, 
MI, Italia) so that they displayed oestrus on the same day in which the in vitro insemination was performed 
(termed day 0). Only animals with a clinically detectable and well-developed corpus luteum (CL), received one 
fresh or one cryopreserved in vitro-CTR embryo or one fresh or cryopreserved in vitro + MV embryo 7 days after 
oestrus. Embryo transfer was performed into the uterine horn ipsilateral to the CL. On day 28 after transfer, and 
on day 70, pregnancy status was established by ultrasound.
In vivo embryo production. Three Holstein-Friesian cows, 3 to 4 years old, with a history of normal fertil-
ity, were enrolled in this study. After detection of a well-developed CL, the animals were treated with a luteolytic 
PGF2-α dose and, nine days after induced estrus, the cows were superovulated with a combination of FSH and 
LH (Pluset, Calier SA, Barcelona, Spain) at the total dose of 1,000 U.I. in ten decreasing doses for 5 days (3, 3, 2.5, 
2.5, 2, 2, 1.5, 1.5, 1, 1 ml). The cows were inseminated twice, at 12 hour interval, starting 12 h after onset of oes-
trus, with the same cryopreserved semen. Seven days after artificial insemination, embryos were collected under 
epidural anesthesia by procaine hydrochloride (IZO, Brescia, Italy). The uteri were non-surgically flushed with 
Ringer’s solution (Terumo, Tokyo, Japan) containing 0.1% fetal calf serum (FCS) through a multi-eye 16-French 
embryo collection catheter (Nipro, Osaka, Japan).
Collected embryos were counted and evaluated following the IETS criteria. Only grade 1 blastocysts were used 
for genomic study, after washing in sterile PBS and immediate cryopreservation in liquid nitrogen.
RNA isolation. Samples for RNA isolation were obtained from pools of 10 embryos each for each condition 
(in vivo, in vitro-CTR and in vitro + MVs). Total RNA was isolated by NucleoSpin1 miRNA kit (Macherey-Nagel, 
Germany) following the protocol, in combination with TRIzol (Invitrogen, Carlsbad, CA, USA) lysis with large 
and small RNA in a single fraction (total RNA), with few modifications: the final step of RNA elution from 
column was performed using a minimum amount of nuclease free water (14 µl). Quality and concentration of 
RNA were determined using Agilent 2100 Bioanalyzer (Santa Clara, CA, USA). The isolated RNAs were stored 
at −80 °C until use.
Library preparation and sequencing. Nine libraries were obtained working in triplicate for each con-
dition (in vivo, in vitro-CTR and vitro + MVs). Libraries were prepared using the TruSeq Small RNA Library 
Preparation kit, according to manufacturer’s instructions (Illumina). Small non-coding RNA (snc-RNAs) librar-
ies were pooled together and purified with Agencourt®AMPure® XP (Beckman, Coulter, Brea, CA) (1 Vol. sam-
ple: 1.8 Vol. beads) twice. Concentration and quality of libraries were assessed by Agilent 2100 Bioanalyzer prior 
sequencing on a single lane of Illumina Hiseq. 3000 (San Diego, CA, USA).
miRNA data analysis. MiRNA analysis was performed as previously reported42: after quality checking 
with FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and trimming with Trimmomatic43, 
Illumina sequences were input to miRDeep244 for miRNA detection and discovery. Bos taurus miRNAs available 
at MirBase (http://www.mirbase.org/) were used to identify known miRNAs. Known miRNAs from related spe-
cies (sheep, horse, and goat) available at MirBase were also input into miRDeep2 to support classification of novel 
miRNAs. The miRDeep2 quantifier module was used to quantify expression and retrieve counts for the detected 
known and novel miRNAs. Differential expression analyses between samples were run with the Bioconductor 
edgeR package (version 2.4) (false discovery rate [FDR] < 0.05)45. MicroRNA cluster analysis was performed 
with Genesis46.
miRNA validation by quantitative polymerase chain reaction (q-PCR). Samples of isolated RNA 
were pooled to obtain three samples representing each treatment (in vivo, in vitro-CTR and in vitro + MVs) 
that were retro-transcribed using the miScript II RT Kit following the manufacturer’s instructions (Qiagen, 
Inc., Valencia, CA, USA). Quantitative real-time (qPCR) and reverse transcription polymerase chain reaction 
(RT-PCR) was carried out as previously reported47 with some modification. cDNAs were firstly preamplified using 
miScript preAMP kit (Qiagen, Inc.) following the manufacturer’s instructions except that miScript Primers were 
used instead of miScript PreAMP Primer Mix. Pre-amplification reactions were done in 10 µl volumes containing 
5x miScript PreAMP Buffer (2 μl), HotStarTaq DNA Polymerase (0.8) μl, miScript Primer (0.4 μl), RNase-free 
water (4.4 μl), miScript PreAMP Universal Primer (0.4 μl), template cDNA (2 μl). Each amplified cDNA was 
quantified using QuantStudio 6 Flex Real-Time PCR System (Thermo Fisher Scientific, Waltham, MA, USA) 
with miScript SYBR Green PCR Kit (Qiagen, Inc.). Reactions were performed in 10 µl volumes containing 1 μl 
of each miscript Primer and 1 μl mL of universal reverse primer (Qiagen, Inc.), 2 μl cDNA, 1 μl RNase-free water 
and 5 μl QuantiTect SYBR Green PCR Master Mix according to the manufacturer’s protocols. The same specific 
miScript Primers were used in both pre-amplification and real-time reactions. The primers used for bta-let-7a-5p, 
bta-miR-130a, bta-miR-34a, bta-miR-423-5p, bta-miR-486 were Hs_let-7a_2, Hs_miR-130a_1, Hs_miR-34a_1, 
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Hs_miR-423-5p_1, Hs_miR-486_1 miScript Primer Assay (Qiagen, Inc.), respectively. For the normalization, the 
references U6 small nuclear RNA Hs_RNU6-2_11 and SNORD95 small nucleolar RNA, C/D box 95 miScript 
Primer (Qiagen, Inc.) were used. Negative controls using water in place of sample were performed alongside each 
reaction. Reactions were run using the cycling parameters of 95 °C for 15 min, 40 cycles of 94 °C for 15 s, 55 °C for 
30 s and 70 °C for 30 s. Relative expression levels for each treatment were calculated using the 2−ΔΔCt method48.
Statistical analyses. Statistical analyses were performed by ANOVA with non-parametric Kruskall-Wallis 
test and for pregnancy rate by chi square. Differences were considered statistically significant at P < 0.05.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on request.
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